316 related articles for article (PubMed ID: 34855246)
21. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
Eur J Cancer; 2023 Nov; 193():113252. PubMed ID: 37708630
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
[TBL] [Abstract][Full Text] [Related]
23. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
Rebeca T; Giselle P; Litchman GH; Rigel DS
J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
[TBL] [Abstract][Full Text] [Related]
24. Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic review and meta-analysis.
Genders RE; Weijns ME; Dekkers OM; Plasmeijer EI
J Eur Acad Dermatol Venereol; 2019 May; 33(5):828-841. PubMed ID: 30793804
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous squamous cell carcinoma: state of the art, perspectives and unmet needs.
Heppt MV; Leiter U
J Dtsch Dermatol Ges; 2023 Apr; 21(4):421-424. PubMed ID: 36999577
[TBL] [Abstract][Full Text] [Related]
26. Advanced cutaneous squamous cell carcinoma: how is it defined and what new therapeutic approaches are available?
Soura E; Gagari E; Stratigos A
Curr Opin Oncol; 2019 Sep; 31(5):461-468. PubMed ID: 31394558
[TBL] [Abstract][Full Text] [Related]
27. Cemiplimab for locally advanced cutaneous squamous cell carcinoma: safety, efficacy, and position in therapy panel.
Lebas E; Marchal N; Rorive A; Nikkels AF
Expert Rev Anticancer Ther; 2021 Apr; 21(4):355-363. PubMed ID: 33554680
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of locally advanced and metastatic cutaneous squamous cell carcinoma.].
Greco S; Pugliese G; Rimini M; Depenni R
Recenti Prog Med; 2021 Jun; 112(6):69e-74e. PubMed ID: 34128944
[TBL] [Abstract][Full Text] [Related]
29. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
30. A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis.
Cañueto J; Tejera-Vaquerizo A; Redondo P; Botella-Estrada R; Puig S; Sanmartin O
Actas Dermosifiliogr (Engl Ed); 2020 May; 111(4):281-290. PubMed ID: 32359704
[TBL] [Abstract][Full Text] [Related]
31. Challenges and new perspectives in the treatment of advanced cutaneous squamous cell carcinoma.
Brancaccio G; Moscarella E; Briatico G; Verolino P; Alfano R; Argenziano G
Minerva Med; 2020 Dec; 111(6):589-600. PubMed ID: 32955822
[TBL] [Abstract][Full Text] [Related]
32. High-risk cutaneous squamous cell carcinoma.
Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
[TBL] [Abstract][Full Text] [Related]
33. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.
Metchnikoff C; Mully T; Singer JP; Golden JA; Arron ST
J Am Acad Dermatol; 2012 Nov; 67(5):829-35. PubMed ID: 22285618
[TBL] [Abstract][Full Text] [Related]
34. Beyond the dermis-high-risk invasive squamous cell carcinoma: a retrospective review.
Sood A; Bivona L; Mahkzoumi Z; Hausner P; Miller K; Regine WF; Snider J; Ng VY
J Wound Care; 2020 Oct; 29(10):556-561. PubMed ID: 33052788
[TBL] [Abstract][Full Text] [Related]
35. Update on the management of high-risk squamous cell carcinoma.
LeBoeuf NR; Schmults CD
Semin Cutan Med Surg; 2011 Mar; 30(1):26-34. PubMed ID: 21540018
[TBL] [Abstract][Full Text] [Related]
36. Patterns of major cutaneous surgeries and reconstructions in patients with cutaneous squamous cell carcinoma in the USA.
Chen CI; Jalbert JJ; Wu N; Ruiz ES
Future Oncol; 2024 Apr; 20(11):691-701. PubMed ID: 37994593
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous squamous cell carcinoma. Italian Guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines.
Peris K; Alaibac M; Argenziano G; Di Stefani A; Fargnoli MC; Frascione P; Gualdi G; Longo C; Moscarella E; Naldi L; Pellacani G; Pimpinelli N; Quaglino P; Salgarello M; Sollena P; Valentini V; Zalaudek I; Calzavara-Pinton PG;
G Ital Dermatol Venereol; 2018 Dec; 153(6):747-762. PubMed ID: 29898593
[TBL] [Abstract][Full Text] [Related]
38. Update of the Management of Cutaneous Squamous-cell Carcinoma.
Maubec E
Acta Derm Venereol; 2020 Jun; 100(11):adv00143. PubMed ID: 32346744
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):237-247. PubMed ID: 29332704
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
Al-Rohil RN; Tarasen AJ; Carlson JA; Wang K; Johnson A; Yelensky R; Lipson D; Elvin JA; Vergilio JA; Ali SM; Suh J; Miller VA; Stephens PJ; Ganesan P; Janku F; Karp DD; Subbiah V; Mihm MC; Ross JS
Cancer; 2016 Jan; 122(2):249-57. PubMed ID: 26479420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
